Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms- |
Target |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ascites | Phase 1 | - | - | |
Kidney Neoplasms | Phase 1 | NL | - | |
Malignant ascites | Phase 1 | NL | - | |
Malignant Pleural Effusion | Phase 1 | - | - | |
Pleural Effusion | Phase 1 | NL | - | |
Renal Cell Carcinoma | Phase 1 | - | - |